Questions? Feedback? powered by Olark live chat software
caspase inhibitor,pan-caspase inhibitor,z-vad-fmk,zvadfmk,zvad-fmk,z-vadfmk,z vad fmk,z vadfmk,zvad fmk,z-valyladeninylaspartate-fmk,fitc-vad-fmk,fitc vad fmk,fitcvadfmk,apoptosis,programmed cell death,val-ala-asp,in situ marker,in vivo caspase,caspase indicator,high-throughput screening,hts,robotics,high-throughput systems,caspase,caspace,g746
CaspACE FITC-VAD-FMK In Situ Marker is a fluorescent analog of the pan caspase inhibitor Z-VAD-FMK that is used to assay for caspase activity in situ.
CaspACE FITC-VAD-FMK In Situ Marker is a fluorescent analog of the pan caspase inhibitor Z-VAD-FMK (carbobenzoxy-valyl-alanyl-aspartyl-[O-methyl]-fluoromethylketone). The fluorescein isothiocyanate (FITC) group has been substituted for the carbobenzoxy (Z) N-terminal blocking group to create the fluorescent apoptosis marker. This structure allows delivery of the inhibitor into the cell where it irreversibly binds to activated caspases. The FITC label allows for a single-reagent addition to assay for caspase activity in situ. The FITC-VAD-FMK is supplied as a 5mM solution in DMSO and is intended for in situ monitoring of caspase activity by fluorescence detection. The suggested concentration for use in anti-Fas-treated Jurkat cell culture is 10uM.

E: care@invitro.com.au
P: 1300 552 003